Pharmaceutical manufacturers of Levothyroxine in USA

Headquartered in Mumbai, India, Lupin is a global pharmaceutical leader with a footprint across the U.S., LATAM, APAC, EMEA and India, with products distributed in over 100 markets. With a diverse portfolio of over 1,200 products, Lupin remains committed to its mission of making quality healthcare accessible to the communities we serve. Our visionary Founder, Dr. Desh Bandhu Gupta, instilled in us the importance of offering quality, affordable and innovative medicines and being a responsible corporate citizen, making a positive difference to patients, communities and the environment.

AbbVie Contract Manufacturing boasts more than three decades of expertise in AbbVie's manufacturing sector. Operating as an integrated CMO, it harnesses extensive knowledge, cooperation, and state-of-the-art facilities, delivering comprehensive services to customers across various domains such as development, production, compliance, and marketing, while ensuring adherence to the highest international benchmarks. Additionally, AbbVie Contract Manufacturing aids clients in streamlining manufacturing, optimizing supply networks, expediting time-to-market, ensuring adherence to regulations, and providing unparalleled quality.

Established in Darmstadt, Germany in 1668 by Friedrich Jacob Merck, Merck KGaA stands as the oldest pharmaceutical and chemical corporation globally. It is renowned for its pioneering and high-quality advanced products in the fields of healthcare, life science, and performance materials. Internationally, the company is recognized as Merck, while operating as EMD Serono in the Biopharma sector, as MilliporeSigma in the Life Science sector, and as EMD Performance Materials in the materials sector in the United States and Canada.

With more than six decades of experience as a leading supplier of materials to the pharmaceutical sector, we comprehend the requirements necessary to support our clients' achievements. Solvay possesses a diverse range of specialty polymers that empower pharmaceutical firms to create novel and improved applications, ultimately ensuring safer and more effective outcomes for patients worldwide

FAREVA stands as a prominent global pharmaceutical CDMO with leading expertise in the development and production of a wide variety of Drug Products and Active Pharmaceutical Ingredients (APIs). The company has a workforce of 13,000 individuals spread across 41 manufacturing facilities situated in 13 countries across EMEA and the Americas. Among these facilities, 18 are exclusively dedicated to pharmaceutical operations. FAREVA’s API division carries out its activities in 3 European locations situated in France and Germany.